These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 351526)

  • 41. Trypanosoma cruzi: infection of T lymphocytes and their destruction by antibody-dependent cell-mediated cytotoxicity.
    Velge P; Kusnierz JP; Ouaissi A; Marty B; Pham BN; Capron A
    Eur J Immunol; 1991 Sep; 21(9):2145-52. PubMed ID: 1909643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Degradation of cellular ribonucleic acid in Newcastle disease virus infected cells.
    Huo WH; Wilson DE
    J Gen Virol; 1969 Mar; 4(2):245-51. PubMed ID: 5772489
    [No Abstract]   [Full Text] [Related]  

  • 43. Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL.
    Low HP; Santos MA; Wizel B; Tarleton RL
    J Immunol; 1998 Feb; 160(4):1817-23. PubMed ID: 9469442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxygen-derived radicals from Trypanosoma cruzi-stimulated human neutrophils.
    Docampo R; Casellas AM; Madeira ED; Cardoni RL; Moreno SN; Mason RP
    FEBS Lett; 1983 May; 155(1):25-30. PubMed ID: 6301881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway.
    Garg N; Nunes MP; Tarleton RL
    J Immunol; 1997 Apr; 158(7):3293-302. PubMed ID: 9120286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temporal changes of [3H]uridine and [14C]thymidine incorporation and total organ DNA and RNA in rat thymus.
    Petricevic M; Denko CW; Messineo L
    Thymus; 1981 Apr; 2(6):355-9. PubMed ID: 6168045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Age related changes in total DNA and RNA and incorporation of uridine and thymidine in rat brain.
    Petricevic M; Denko CW; Messineo L
    Int J Biochem; 1983; 15(5):751-3. PubMed ID: 6190688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biochemical characterization of a factor released by macrophages.
    Opitz HG; Niethammer D; Jackson RC; Lemke H; Huget R; Flad HD
    Cell Immunol; 1975 Jul; 18(1):70-5. PubMed ID: 1139637
    [No Abstract]   [Full Text] [Related]  

  • 49. Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 on the expression of IL-2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytes.
    Kierszenbaum F; de Diego JL; Fresno M; Sztein MB
    Eur J Immunol; 1999 May; 29(5):1684-91. PubMed ID: 10359123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.
    Kierszenbaum F; Lopez HM; Sztein MB
    Immunology; 1994 Mar; 81(3):462-7. PubMed ID: 8206517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cryptic epitope explains the failure of a monoclonal antibody to bind to certain isolates of Trypanosoma cruzi.
    Kirchhoff LV; Hieny S; Shiver GM; Snary D; Sher A
    J Immunol; 1984 Nov; 133(5):2731-5. PubMed ID: 6207242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Synchronization of DNA synthesis in spleen cells following repeated contact with an antigen].
    Gusev VP
    Biull Eksp Biol Med; 1969 Feb; 67(2):79-82. PubMed ID: 5821440
    [No Abstract]   [Full Text] [Related]  

  • 53. Elevated rate of 3H-uridine incorporation in regressing rat ventral prostate.
    Stanisic T; Sadlowski R; Lee C; Grayhack JT
    Invest Urol; 1978 Jul; 16(1):15-8. PubMed ID: 689833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis.
    Krettli AU; Weisz-Carrington P; Nussenzweig RS
    Clin Exp Immunol; 1979 Sep; 37(3):416-23. PubMed ID: 116784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle.
    Kierszenbaum F; Moretti E; Sztein MB
    Biol Res; 1993; 26(1-2):197-207. PubMed ID: 7670532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Humoral antibody response in mice infected with Trypanosoma cruzi.
    Cardoni RL; Rimoldi MT; Esteva M; de Bracco MM
    Medicina (B Aires); 1986; 46(4):435-9. PubMed ID: 3106748
    [No Abstract]   [Full Text] [Related]  

  • 58. [Autoradiographic studies on DNA, RNA and protein synthesis in vitro of human bone marrow cells].
    Kimura M
    Nihon Ketsueki Gakkai Zasshi; 1966 Nov; 29(6):890-909. PubMed ID: 6009655
    [No Abstract]   [Full Text] [Related]  

  • 59. Trypanosoma cruzi: expression of antigens on the membrane surface of parasitized cells.
    Araujo FG
    J Immunol; 1985 Dec; 135(6):4149-54. PubMed ID: 3934275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers.
    Ubillos L; Freire T; Berriel E; Chiribao ML; Chiale C; Festari MF; Medeiros A; Mazal D; Rondán M; Bollati-Fogolín M; Rabinovich GA; Robello C; Osinaga E
    Int J Cancer; 2016 Apr; 138(7):1719-31. PubMed ID: 26519949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.